Aptevo Stock Rallies After Posting First Complete Remission In Early Acute Myeloid Leukemia Trial<blockquote>Aptevo在早期急性髓系白血病试验中首次完全缓解后股价上涨</blockquote>
Aptevo Therapeutics Inc has announced a clinical update for its Phase 1b Expansion trial evaluating